This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wilson, M. Articles by Ware, D. Search for Related Content PubMed PubMed Citation Articles by Wilson, M. Articles by Ware, D.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Dec 1997, 3112-3115, Vol 35, No. 12
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group [In Process Citation]

M Wilson, JS Remington, C Clavet, G Varney, C Press and D Ware
Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. myw1@cdc.gov

As a result of reports received by the Food and Drug Administration (FDA) of false-positive results obtained with FDA-cleared in vitro diagnostic kits for the detection of Toxoplasma-specific human immunoglobulin M (IgM) antibodies, an FDA-sponsored evaluation of six kits was performed. A battery of 258 serum specimens, including 30 specimens drawn 1 to 5 months after initial Toxoplasma infection and 228 specimens from Toxoplasma IgG-positive individuals, Toxoplasma IgG- negative individuals, rheumatoid factor-positive persons, and persons determined to be Toxoplasma IgM positive by commercially available assays, was assembled, randomly assorted, and coded. The battery was tested at the FDA with six commercially available kits, at the Palo Alto Medical Foundation (PAMF) by the PAMF double-sandwich IgM enzyme- linked immunosorbent assay (PAMF IgM ELISA), and at the Centers for Disease Control and Prevention (CDC) by the CDC EIA IgM. The results of the PAMF IgM ELISA that were obtained with the battery were considered to be the "gold standard" for this study; specificity rates were computed by considering the PAMF results to be 100% specific. Sensitivity and specificity rates were found to be as follows: CDC EIA IgM, 100 and 99.1%, respectively; Abbott IMx Toxo IgM, version 1, 100 and 77.5%, respectively; Abbott IMx Toxo IgM, version 2, 93.3 and 97.3%, respectively; Abbott Toxo-M EIA, 100 and 84.2%, respectively; BioMerieux Vitek VIDAS Toxo IgM, 100 and 98.6%, respectively; BioWhittaker Toxocap-M, 100 and 95.9%, respectively; Gull Toxo IgM, 97 and 85.6%, respectively; and Sanofi Diagnostics Pasteur Platelia Toxo IgM, 100 and 96.8%, respectively. Although the extent of false-positive reactions with these kits cannot be calculated because the study was retrospective and sample choices were biased, the results may be useful as an indicator of the relative specificities of these kits.

This article has been cited by other articles:

• Beghetto, E., Spadoni, A., Bruno, L., Buffolano, W., Gargano, N. (2006). Chimeric Antigens of Toxoplasma gondii: Toward Standardization of Toxoplasmosis Serodiagnosis Using Recombinant Products.. J. Clin. Microbiol. 44: 2133-2140 [Abstract] [Full Text]  
• Jin, S., Chang, Z. Y., Ming, X., Min, C. L., Wei, H., Sheng, L. Y., Hong, G. X. (2005). Fast Dipstick Dye Immunoassay for Detection of Immunoglobulin G (IgG) and IgM Antibodies of Human Toxoplasmosis. CVI 12: 198-201 [Abstract] [Full Text]  
• Kaul, R., Chen, P., Binder, S. R. (2004). Detection of Immunoglobulin M Antibodies Specific for Toxoplasma gondii with Increased Selectivity for Recently Acquired Infections. J. Clin. Microbiol. 42: 5705-5709 [Abstract] [Full Text]  
• NIMRI, L., PELLOUX, H., ELKHATIB, L. (2004). DETECTION OF TOXOPLASMA GONDII DNA AND SPECIFIC ANTIBODIES IN HIGH-RISK PREGNANT WOMEN. Am J Trop Med Hyg 71: 831-835 [Abstract] [Full Text]  
• Montoya, J. G., Huffman, H. B., Remington, J. S. (2004). Evaluation of the Immunoglobulin G Avidity Test for Diagnosis of Toxoplasmic Lymphadenopathy. J. Clin. Microbiol. 42: 4627-4631 [Abstract] [Full Text]  
• Flori, P., Tardy, L., Patural, H., Bellete, B., Varlet, M.-N., Hafid, J., Raberin, H., Sung, R. T. M. (2004). Reliability of Immunoglobulin G Antitoxoplasma Avidity Test and Effects of Treatment on Avidity Indexes of Infants and Pregnant Women. CVI 11: 669-674 [Abstract] [Full Text]  
• Montoya, J. G., Liesenfeld, O., Kinney, S., Press, C., Remington, J. S. (2002). VIDAS Test for Avidity of Toxoplasma-Specific Immunoglobulin G for Confirmatory Testing of Pregnant Women. J. Clin. Microbiol. 40: 2504-2508 [Abstract] [Full Text]  
• Gomes-Solecki, M. J. C., Wormser, G. P., Schriefer, M., Neuman, G., Hannafey, L., Glass, J. D., Dattwyler, R. J. (2002). Recombinant Assay for Serodiagnosis of Lyme Disease Regardless of OspA Vaccination Status. J. Clin. Microbiol. 40: 193-197 [Abstract] [Full Text]  
• Vlaspolder, F., Singer, P., Smit, A., Diepersloot, R. J. A. (2001). Comparison of Immulite with Vidas for Detection of Infection in a Low-Prevalence Population of Pregnant Women in The Netherlands. CVI 8: 552-555 [Abstract] [Full Text]  
• Suzuki, Y., Ramirez, R., Press, C., Li, S., Parmley, S., Thulliez, P., Remington, J. S. (2000). Detection of Immunoglobulin M Antibodies to P35 Antigen of Toxoplasma gondii for Serodiagnosis of Recently Acquired Infection in Pregnant Women. J. Clin. Microbiol. 38: 3967-3970 [Abstract] [Full Text]  
• Li, S., Galvan, G., Araujo, F. G., Suzuki, Y., Remington, J. S., Parmley, S. (2000). Serodiagnosis of Recently Acquired Toxoplasma gondii Infection Using an Enzyme-Linked Immunosorbent Assay with a Combination of Recombinant Antigens. CVI 7: 781-787 [Abstract] [Full Text]  
• Aubert, D., Maine, G. T., Villena, I., Hunt, J. C., Howard, L., Sheu, M., Brojanac, S., Chovan, L. E., Nowlan, S. F., Pinon, J. M. (2000). Recombinant Antigens To Detect Toxoplasma gondii-Specific Immunoglobulin G and Immunoglobulin M in Human Sera by Enzyme Immunoassay. J. Clin. Microbiol. 38: 1144-1150 [Abstract] [Full Text]  
• Li, S., Maine, G., Suzuki, Y., Araujo, F. G., Galvan, G., Remington, J. S., Parmley, S. (2000). Serodiagnosis of Recently Acquired Toxoplasma gondii Infection with a Recombinant Antigen. J. Clin. Microbiol. 38: 179-184 [Abstract] [Full Text]  
• Levine, D., Grossberg, R., Tilton, R., Banks, P., Rosenfeld, A. (1998). Are Current Regulations for Approval of In Vitro Diagnostic Devices Adequate?. JAMA 280: 187-189 [Full Text]